(Reuters) -PerkinElmer Inc on Monday agreed to sell three of its businesses to private equity firm New Mountain Capital for up to $2.45 billion in cash, as it looks to focus on its life sciences and ...

PerkinElmer is slimming down to focus solely on diagnostics and life sciences research, selling off its other businesses in a deal that will hand it $2.3 billion in cash. The funding is expected to ...

PerkinElmer. Inc. PKI recently launched two ready-to-use Homogenous Time Resolved Technology (HTRF) and AlphaLISA no-wash assay kits. These kits have been created to quickly and easily identify and ...

PerkinElmer is acquiring Covaris, which manufactures applications and solutions for life science companies, as part of an effort to expand its life sciences portfolio. The biotech announced Monday ...

PerkinElmer said today it agreed to acquire BioLegend, a provider of life science antibodies and reagents, for approximately $5.25 billion in cash and stock—the largest acquisition in the buyer’s ...

PerkinElmer, a global manufacturer with more than 500 employees in Shelton, is eliminating close to 75 jobs as it moves four product lines to England and Singapore. The company, headquartered in ...

Massachusetts life science firm PerkinElmer plans to acquire San Diego antibody company BioLegend for $5.25 billion, according to an announcement from the company on Monday. About $2.2 billion of the ...